Severe herpes virus 6 interstitial pneumonia in an infant with three variants in genes predisposing to lung disease

Domenico Umberto De Rose1, Cinzia Auriti1, Simona Lozzi1

  • 1Neonatal Intensive Care Unit, Department of Medical and Surgical Neonatology, "Bambino Gesù" Children's Hospital IRCCS, Rome, Italy.

Insights

Human herpesvirus 6 (HHV-6) can cause severe pneumonia in neonates. This case highlights the need to consider HHV-6 and genetic factors in severe respiratory distress, with viral load indicating treatment response.

Area of Science:

  • Neonatology
  • Virology
  • Genetics

Background:

  • Human herpesvirus 6 (HHV-6) infections are common in children, usually mild.
  • Congenital HHV-6 infections occur in 1% of neonates and can be severe.
  • The role of HHV-6 in neonatal severe pneumonia is not well understood.

Observation:

  • A healthy infant developed severe, late-onset interstitial pneumonia with high HHV-6 viral load in bronchoalveolar lavage (BAL) fluid.
  • The infant required mechanical ventilation and received antiviral and supportive therapies for six weeks.
  • Genetic analysis revealed variants in DRC1, RSPH9, and MUC5B genes associated with respiratory insufficiency.

Findings:

  • Persistent high HHV-6 genome load in BAL fluid was observed in a neonate with severe interstitial pneumonia.
  • Genetic variants, including a likely pathogenic DRC1 variant, were identified, suggesting a potential genetic predisposition.
  • Despite aggressive treatment, the infant succumbed to the illness at nine months of age.

Implications:

  • HHV-6 should be considered in the differential diagnosis of severe, late-onset neonatal respiratory distress.
  • Testing for genetic factors predisposing to or modifying respiratory insufficiency is recommended.
  • HHV-6 viral load in BAL fluid may serve as a biomarker for antiviral therapy response.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.5K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
393
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.6K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.4K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
615